AiPharma

AiPharma is a biopharmaceutical company focused on the discovery, development, and commercialization of oral therapies to address unmet medical needs for patients with life-threatening viral diseases. With deep expertise in antiviral drug development, nucleotide chemistry, biology, biochemistry, and virology, AiPharma has established a nucleotide prodrug platform to develop novel candidates for treating single-stranded RNA (ssRNA) viruses.